Thyroxavet 400 microgram tablets for dogs and cats
Thyroxavet 400 microgram tablets for dogs and cats
Authorised
- Anhydrous levothyroxine sodium
Product identification
Medicine name:
Thyroxavet 400 microgram tablets for dogs and cats
THYROXAVET 400 μικρογραμμάρια δισκία για σκύλους και γάτες
Active substance:
- Anhydrous levothyroxine sodium
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Anhydrous levothyroxine sodium400.00/microgram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- 10 Aluminium - PVC/Alu/oPA blisters of 10 tablets packed in cardboard box
- 25 Aluminium - PVC/Alu/oPA blisters of 10 tablets packed in cardboard box
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 86532/23-09-2021/K-0245902
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0325/002
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Lithuania
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 8/06/2022
How useful was this page?:
